Medtronic Defibrillator Lead Recall Attorneys
New Data from STOP AF Pivotal Trial Announced By Medtronic
- E-mail this Article
- Print this Article
- Text Size: A A
Editor: Marc Jay Bern
Profession: Defective Medical Device Lawyer
Category: Medtronic News
Medtronic released new STOP AF clinical data which shows the number of paroxysmal atrial fibrillation (AF) patients reporting AF symptoms declined by 80 percent after treatment with the Artic Front Cardiac CryoAblation Catheter System.
Additionally, as reported in the quality-of-life questionnaire (SF-36) results, all patients randomized and treated with the Arctic FrontCardiac CryoAblation Catheter System reported significant improvements in physical and mental quality-of-life factors when compared to baseline measurements (P<0.001).
Read the rest of the article.
Trackback Pings
TrackBack URL for this entry:
http://myblog.clarislaw.com/usa/mt-tb.cgi/3497
